Indonesia

Tuberculosis profile

| High TB burden | High HIV burden | High MDR-TB burden |

Population 2012

247 million

Estimates of TB burden * 2012

Mortality (excludes HIV+TB)
Mortality (HIV+TB only)
Prevalence (includes HIV+TB)
Incidence (includes HIV+TB)
Incidence (HIV+TB only)
Case detection, all forms (%)
TB case notifications 2012
New cases
Smear-positive
Smear-negative
Smear-unknown / not done
Extrapulmonary
Other
Total new

Number (thousands)
67 (30120)
2.1 (1.83)
730 (3501 200)
460 (380540)
7.5 (5.69.7)
72 (6187)

Rate
(per 100 000 population)
27 (1248)
0.86 (0.741.2)
297 (144506)
185 (153220)
3.1 (2.33.9)

100
50
0
1990

5 942
467
954
1 179

322 882

8 542

(%)
(70)
(5)
(11)
(14)

New cases
M:F ratio
Age < 15

328 824

Smear-positive
1.5
1 703

Total cases notified

Smear-negative/ unknown/
not done
1.3
22 956

Laboratories
Smear (per 100 000 population)
Culture (per 5 million population)
Drug susceptibility testing (per 5 million population)
Is second-line drug susceptibility testing available?
Treatment success rate 2011 (%)
New smear-positive and/or culture-positive
New smear-negative/extrapulmonary
Retreatment

1998

2002

2006

2010

2006

2010

(Rate per 100 000 population)

800
400
0
1990

1994

1998

2002

Prevalence

___

Other (history unknown)

Total new and relapse

1994

Mortality (excludes HIV+TB)

___

(%) Retreatment cases

202 319 (63) Relapse
104 866 (32) Treatment after failure
Treatment after default
15 697 (5) Other
Total retreatment

***
(Rate per 100 000 population per year)

(Rate per 100 000 population per year)

300

331 424

Extrapulmonary
0.9
2 684
2012
2.3
0.9
0.1
Yes, in country

200
100
0
1990

__
___

1994

1998

2002

2006

2010

Notifications ___ Incidence

Incidence (HIV+TB only)

Treatment success rate (%)

90

90
85
71

70

Is rifampicin used
throughout treatment for
new patients?

TB/HIV 2012
TB patients with known HIV status
HIV-positive TB patients
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)
HIV-positive TB patients on antiretroviral therapy (ART)
HIV-positive people screened for TB
HIV-positive people provided with IPT

Number
2 676
754
133
221
22 677

Yes
(%)
(<1)
(28)
(18)
(29)

50
30
1995 1997 1999 2001 2003 2005 2007 2009

__ New smear-positive and/or culture-positive

__New smear-negative/extrapulmonary __
Retreatment
(Number of patients)
3000
2000

Estimates of MDR-TB burden 2012*

% of TB cases with MDR-TB
MDR-TB cases among notified pulmonary
TB cases
Reported cases of MDR-TB 2012
Cases tested for MDR-TB
Laboratory-confirmed MDR-TB cases
Patients started on MDR-TB treatment
Financing TB control
National TB programme budget (US$ millions)
% Funded domestically
% Funded internationally
% Unfunded

New
1.9 (1.42.5)
5 800 (4 3007 700)
New
2 (<1%)
2

Retreatment
12 (8.117)

1000
0
2003

1 000 (6901 500)

Retreatment
821 (10%)
425

Total
824
428
426
2013
119
14%
35%
51%

2005

2007

2009

2011

__ HIV-positive TB patients
__on CPT __on ART
Total budget (US$ millions)
120
80
40
0
2009

__
__

2010

Funded domestically
Unfunded

Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
* Ranges represent uncertainty intervals
Generated: 2014-02-23

2011

__

2012

2013

Funded internationally

Data: www.who.int/tb/data